122 related articles for article (PubMed ID: 3109817)
1. In vitro evaluation of Ro 23-6240, a new fluorinated 4-quinolone.
Stobberingh EE; Houben AW; van Boven CP
Chemotherapy; 1987; 33(3):197-203. PubMed ID: 3109817
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of the new 4-quinolone compound Ro 23-6240.
Clarke AM; Zemcov SJ
Eur J Clin Microbiol; 1987 Apr; 6(2):161-4. PubMed ID: 3109895
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of Ro 23-6240, a new difluoroquinolone derivative, compared with that of other antimicrobial agents.
Manek N; Andrews JM; Wise R
Antimicrob Agents Chemother; 1986 Aug; 30(2):330-2. PubMed ID: 3094444
[TBL] [Abstract][Full Text] [Related]
4. Comparative in vitro activity of RO 23-6240 (fleroxacin), a new 4-quinolone derivative.
Machka K; Braveny I
Eur J Clin Microbiol; 1987 Aug; 6(4):482-5. PubMed ID: 3117538
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of Ro 23-9424, a dual-action cephalosporin, compared with activities of other antibiotics.
Gu JW; Neu HC
Antimicrob Agents Chemother; 1990 Feb; 34(2):189-95. PubMed ID: 2327765
[TBL] [Abstract][Full Text] [Related]
6. In vitro activities of a dual-action antibacterial agent, Ro 23-9424, and comparative agents.
Beskid G; Fallat V; Lipschitz ER; McGarry DH; Cleeland R; Chan K; Keith DD; Unowsky J
Antimicrob Agents Chemother; 1989 Jul; 33(7):1072-7. PubMed ID: 2782857
[TBL] [Abstract][Full Text] [Related]
7. In vivo evaluation of a dual-action antibacterial, Ro 23-9424, compared to cefotaxime and fleroxacin.
Beskid G; Siebelist J; McGarry CM; Cleeland R; Chan K; Keith DD
Chemotherapy; 1990; 36(2):109-16. PubMed ID: 2107064
[TBL] [Abstract][Full Text] [Related]
8. In vitro characterization of Ro 23-6240.
Stobberingh E; Houben A; Van Boven C
Chemioterapia; 1987 Jun; 6(2 Suppl):154-5. PubMed ID: 3151336
[No Abstract] [Full Text] [Related]
9. In vitro studies of fleroxacin (Ro 23-6240), a new trifluorinated quinolone derivative.
Digranes A; Benonisen E; Salveson A; Zahm F
Chemotherapy; 1988; 34(5):401-10. PubMed ID: 3141116
[TBL] [Abstract][Full Text] [Related]
10. In-vitro activity of fleroxacin.
Georgopoulos A; Breyer S; Georgopoulos M; Mailer H; Graninger W
J Antimicrob Chemother; 1988 Oct; 22 Suppl D():25-9. PubMed ID: 3144544
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic resistance of Staphylococcus aureus, selected Enterobacteriaceae, and Pseudomonas aeruginosa after single and multiple in vitro exposures to ciprofloxacin, levofloxacin, and trovafloxacin.
Gilbert DN; Kohlhepp SJ; Slama KA; Grunkemeier G; Lewis G; Dworkin RJ; Slaughter SE; Leggett JE
Antimicrob Agents Chemother; 2001 Mar; 45(3):883-92. PubMed ID: 11181375
[TBL] [Abstract][Full Text] [Related]
12. The comparative activity of fleroxacin, three other quinolones and eight unrelated antimicrobial agents.
McCarter YS; Mazens-Sullivan MF; Bartlett RC
Chemotherapy; 1992; 38(5):308-18. PubMed ID: 1337507
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of aryl fluoroquinolones, Abbott 56619 and Abbott 56620, compared to ciprofloxacin, norfloxacin and beta-lactams versus multidrug-resistant Enterobacteriaceae and Pseudomonas aeruginosa.
Meyer RD; Liu S
Chemotherapy; 1986; 32(5):425-30. PubMed ID: 3093154
[TBL] [Abstract][Full Text] [Related]
14. In-vitro activity of fleroxacin compared with three other quinolones.
Bremner DA; Dickie AS; Singh KP
J Antimicrob Chemother; 1988 Oct; 22 Suppl D():19-23. PubMed ID: 3144536
[TBL] [Abstract][Full Text] [Related]
15. RO 23-6240 (AM-833), a new fluoroquinolone: in vitro antimicrobial activity and tentative disk diffusion interpretive criteria.
Fuchs PC; Jones RN; Barry AL; Ayers LW; Gavan TL; Gerlach EH; Thornsberry C
Diagn Microbiol Infect Dis; 1987 May; 7(1):29-35. PubMed ID: 3121241
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial activity of Ro 24-6778, a covalent bonding of desmethylfleroxacin and desacetylcefotaxime.
Jones RN
Diagn Microbiol Infect Dis; 1990; 13(3):253-9. PubMed ID: 2116952
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of Ro 23-6240, a new fluorinated 4-quinolone.
Chin NX; Brittain DC; Neu HC
Antimicrob Agents Chemother; 1986 Apr; 29(4):675-80. PubMed ID: 3085584
[TBL] [Abstract][Full Text] [Related]
18. In-vitro and in-vivo antibacterial activity of fleroxacin, a new fluorinated quinolone.
Aoyama H; Inoue M; Mitsuhashi S
J Antimicrob Chemother; 1988 Oct; 22 Suppl D():99-114. PubMed ID: 2849604
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of fleroxacin (Ro23-6240), a new fluorinated 4-quinolone against isolates from cancer patients.
Rolston K; Ho DH; LeBlanc B; Bodey GP
Chemotherapy; 1988; 34(6):448-54. PubMed ID: 3149568
[TBL] [Abstract][Full Text] [Related]
20. Escherichia coli resistant to cephalosporins and quinolones is still susceptible to the cephalosporin-quinolone ester Ro 23-9424.
Pace J; Bertasso A; Georgopapadakou NH
Antimicrob Agents Chemother; 1991 May; 35(5):910-5. PubMed ID: 1649574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]